Mena Mani Industries Ltd (531127)
சுருக்கம்
நிகழ்வுகள்
- சமீபத்திய முடிவுகள்
- Q2 FY27, தாக்கல் செய்யப்பட்டது 4 நவ. 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 29 அக். 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
| Q2 FY27 (₹ கோடி) | மதிப்பு | YoY | QoQ |
|---|---|---|---|
| செயல்பாட்டு லாபம் | ₹0.2 | — | — |
| நிகர லாபம் | ₹0.2 | — | — |
| EPS (₹) | 0.02 | — | — |
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Mena Mani Industries reported standalone revenue from operations of ₹4.44 cr for Q2 FY27 (quarter ended September 30, 2026), doubling from ₹2.14 cr in Q2 FY26. Net profit stood at ₹0.18 cr compared to a loss of ₹0.07 cr in the year-ago quarter, though it declined sharply sequentially from ₹1.10 cr in Q1 FY27. In a strategic pivot, the Board authorized MD Swetank Patel to enter the hotel business (independently or via JV) with fundraising, and to pursue expansion in its wholly-owned subsidiary's software business.
- Standalone Q2 FY27 revenue from operations stood at ₹4.44 cr vs ₹2.14 cr in Q2 FY26
- Net profit for the quarter came in at ₹0.18 cr against a net loss of ₹0.07 cr in Q2 FY26
- H1 FY27 net profit rose to ₹1.28 cr compared to ₹0.09 cr in H1 FY26
- Board authorized MD to enter hotel business and raise funds for the same
- Board approved steps for expansion of software business of wholly owned subsidiary
Mena Mani Industries has scheduled a Board of Directors meeting on Tuesday, November 3, 2026. The board will consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. Additionally, the agenda includes discussing a new line of business for the future growth and development of the company. The trading window remains closed and will reopen 48 hours after the declaration of the financial results.
- Board meeting scheduled for November 3, 2026
- Agenda includes reviewing Q2 and H1 results for the period ended September 30, 2026
- Board will discuss a new line of business for future company growth
- Trading window to reopen 48 hours post declaration of results
Shareholders of Mena Mani Industries approved an increase in the authorised share capital from Rs 16.50 crore to Rs 31.50 crore at the Annual General Meeting held on September 30, 2026. The capital is divided into 31.50 crore equity shares of face value Re 1 each. This involves an alteration of Clause V of the company's Memorandum of Association. The expansion in authorised headroom typically creates room for potential future equity fundraising or corporate actions.
- Authorised share capital increased from Rs 16,50,00,000 to Rs 31,50,00,000
- Total authorised equity shares increased from 16.50 crore to 31.50 crore with face value of Re 1 each
- Shareholder approval received at the AGM held on September 30, 2026
Mena Mani Industries has released its FY 2025-26 Annual Report and notice for its AGM scheduled on September 30, 2026. The company is seeking shareholder approval to nearly double its authorised share capital from ₹16.50 crore to ₹31.50 crore. Additionally, it has proposed enabling the conversion of up to ₹75 crore in promoter group loans into equity shares. Financially, the company's net worth turned positive to ₹1,440.22 lakh as of March 31, 2026, compared to negative ₹84.30 lakh in the previous year.
- Proposed increase in authorised share capital from ₹16.50 crore to ₹31.50 crore (31.50 crore equity shares of ₹1 each)
- Enabling resolution to convert promoter loans of up to ₹75 crore into equity shares
- Net worth recovered to positive ₹1,440.22 lakh as of March 31, 2026, from negative ₹84.30 lakh in FY25
- Net debt-to-equity ratio improved to 0.77 as of March 31, 2026, from -17.00 in March 2025
- Total borrowings stood at ₹1,451.27 lakh alongside cash balances of ₹346.10 lakh as of March 31, 2026
Mena Mani Industries Ltd's Board has approved an increase in its Authorised Share Capital from ₹16.50 crore to ₹31.50 crore. The capital will now consist of 31.50 crore equity shares of face value ₹1 each, up from 16.50 crore equity shares. Consequently, Clause V (Capital Clause) of the Memorandum of Association will be altered, subject to shareholder approval in a general meeting. This increase typically lays the groundwork for future equity fundraising, bonus issues, or conversion of instruments.
- Authorised Share Capital increased from ₹16,50,00,000 to ₹31,50,00,000
- Authorised equity share count increases from 16.50 crore shares to 31.50 crore shares of Re 1 each
- Alteration of Clause V (Capital Clause) of MOA subject to shareholder approval
Mena Mani Industries' Board has approved an increase in its authorized share capital from ₹16.50 crore to ₹31.50 crore, divided into 31.50 crore equity shares of ₹1 each. The Board also approved an amendment to its Memorandum of Association (MoA) to diversify into hotels, resorts, wellness, rehabilitation, and senior citizen care centres. Both proposals are subject to shareholder approval at an upcoming General Meeting. This move paves the way for potential equity fundraises and a strategic business pivot relative to its current net worth of ₹14 crore.
- Authorized share capital increased from ₹16,50,00,000 to ₹31,50,00,000 (shares of ₹1 each)
- Proposed addition of Clause III [A] (8) to MoA to enter hospitality, resorts, wellness, and care centres
- All resolutions subject to member approval in the upcoming General Meeting
Mena Mani Industries Ltd has scheduled a Board of Directors meeting on August 26, 2026. The board will consider approving an increase in the company's authorized share capital, subject to shareholder approval. Furthermore, the company will evaluate adding the hotel business to its main object clause, signalling a potential business diversification or pivot.
- Board of Directors meeting scheduled for Wednesday, August 26, 2026
- Agenda includes proposal to increase Authorised Share Capital subject to member approval
- Agenda includes proposal to insert Hotel Business into the company's main objects clause
- Net worth of the company currently stands at ₹14 Cr
Ashoka Metcast Limited, a major non-promoter shareholder, sold 24,86,112 equity shares representing 2.14% of Mena Mani Industries Limited via open market transactions. Following this sale, Ashoka Metcast's direct holding reduced from 10.76% (1.25 crore shares) to 8.62% (1.00 crore shares). The aggregate holding of Ashoka Metcast along with Persons Acting in Concert (PAC) decreased from 11.11% (1.29 crore shares) to 8.97% (1.04 crore shares). The transaction was completed across the open market over the stated disposal window.
- Ashoka Metcast sold 24,86,112 equity shares, equivalent to a 2.14% stake in the company.
- Ashoka Metcast's individual holding fell from 10.76% (12,500,000 shares) to 8.62% (10,013,888 shares).
- Total combined holding of Ashoka Metcast and PACs reduced from 11.11% (12,904,330 shares) to 8.97% (10,418,218 shares).
- Total equity share capital remains unchanged at Rs 11.62 crore (11,62,06,947 equity shares of Re 1 face value).
Non-promoter entity Akhil Retail Private Limited sold 32,09,424 equity shares (2.76% stake) of Mena Mani Industries Limited via open market transactions between July 9, 2026, and August 17, 2026. Following this sale, the combined holding of Akhil Retail and its Persons Acting in Concert (PAC) decreased from 7.18% (83,41,870 shares) to 4.42% (51,32,446 shares). The company's total equity base remains unchanged at 11,62,06,947 equity shares of Re 1 each.
- Akhil Retail sold 32,09,424 equity shares representing 2.76% of paid-up capital
- Combined shareholding of Akhil Retail & PACs reduced from 7.18% to 4.42%
- Sales took place via open market between July 9, 2026, and August 17, 2026
- Total voting capital of the company stands at 11,62,06,947 shares (face value Re 1 each)
Mena Mani Industries reported a sharp increase in standalone net profit to Rs 1.10 Cr for the quarter ended June 30, 2026, compared to just Rs 0.16 Cr in the same quarter last year. Revenue from operations grew 8% YoY to Rs 4.46 Cr. The profit surge was primarily driven by a reduction in total expenses, which fell to Rs 3.36 Cr from Rs 3.97 Cr YoY, despite higher revenue. Notably, this single quarter's profit exceeds the company's total net profit for the entire FY26 (Rs 0.17 Cr) by over six times.
- Net Profit surged to Rs 1.10 Cr in Q1 FY27 from Rs 0.16 Cr in Q1 FY26
- Revenue from operations increased 8% YoY to Rs 4.46 Cr from Rs 4.13 Cr
- Total expenses decreased to Rs 3.36 Cr from Rs 3.97 Cr in the year-ago period
- Earnings Per Share (EPS) improved significantly to Rs 0.095 from Rs 0.016 YoY
- Quarterly profit of Rs 1.10 Cr is approximately 647% of the total FY26 net profit of Rs 0.17 Cr
Mena Mani Industries has scheduled a board meeting for August 13, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The company, an NBFC with a market capitalization of Rs 205 Cr, reported a TTM revenue of Rs 17 Cr and a marginal TTM PAT of Rs 0.17 Cr. Investors should note the stock's high P/E ratio of 1204.0 and the recent decline in promoter holding from 48.32% to 41.73% in the March 2026 quarter. The trading window for insiders is currently closed and will reopen 48 hours after the results are announced.
- Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results
- Trading window closed for insiders until 48 hours post-result declaration
- Company reported TTM revenue of Rs 17 Cr for FY26
- Promoter holding decreased by 6.59% to 41.73% in the most recent reported quarter (Mar 2026)
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
